Recent advance in amino acid PET combined with MRI in brain gliomas
10.3760/cma.j.cn115354-20220531-00379
- VernacularTitle:氨基酸类PET联合MRI在脑胶质瘤诊疗中的应用
- Author:
Shuangshuang SONG
1
;
Zhenguang WANG
Author Information
1. 青岛大学附属医院核医学科,青岛 266000
- Keywords:
Brain glioma;
Positron-emission tomography;
Magnetic resonance imaging;
Amino acid
- From:
Chinese Journal of Neuromedicine
2022;21(11):1164-1167
- CountryChina
- Language:Chinese
-
Abstract:
Gliomas are the most common primary malignant tumor of the central nervous system, with strong invasion, high disability and mortality, and poor prognosis. The biological distribution characteristics of specific radiopharmaceuticals in amino acid positron emission tomography (PET) could reflect glioma molecular metabolism information, which is complementary to the morphological and functional information of magnetic resonance imaging (MRI); PET combined with MRI play pivotal roles in the diagnosis, biopsy guidance, recurrent monitor and prognosis prediction of gliomas. In this article, the application and research progress of amino acid PET combined with MRI in clinical diagnosis and treatment of brain gliomas are reviewed to provide imaging basis for clinical diagnosis and treatment of gliomas.